Servier

Research organisation

Servier

Description

As an independent international pharmaceutical company, Servier is committed to therapeutic progress for the benefit of patients.

Our ambition is to become a recognised, focused and innovative player in oncology by targeting cancers that are difficult to treat. This is why the Group devotes nearly 70% of its R&D budget to the development of targeted and innovative oncology therapies. In these fields, Servier focuses on a limited number of specific pathologies in which the precise characterisation of patients makes it possible to offer a targeted therapeutic response, thanks to precision medicine.

Servier

Address

905 Rte de Saran
45520 Gidy, France

Contact

christophe.aussourd@servier.com

Description

As an independent international pharmaceutical company, Servier is committed to therapeutic progress for the benefit of patients.

Our ambition is to become a recognised, focused and innovative player in oncology by targeting cancers that are difficult to treat. This is why the Group devotes nearly 70% of its R&D budget to the development of targeted and innovative oncology therapies. In these fields, Servier focuses on a limited number of specific pathologies in which the precise characterisation of patients makes it possible to offer a targeted therapeutic response, thanks to precision medicine.

Matchmaking

Connect with Servier

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways